Company intelligence / Profile preview

Provista Life Sciences

Phoenix, Arizona, United States

Ownership: Private
Development stage: Other

Overview

Provista Life Sciences established a clinical laboratory subsidiary (Provista Diagnostics) to advance three diagnostic blood tests for women's cancers and Alzheimer's disease. The company planned commercial introduction of breast cancer and estrogen-related cancer tests in summer 2007, followed by Alzheimer's test in early 2008.[3]

Therapeutic areas: OncologyNeurology
Modalities: Diagnostic blood test
Industry: Protein Biomarker Diagnostics

Partnerships

GW Medical Technologies (LymPro Test)Biomarker Technologies (BT Test)RCP Diagnostics (RCP-Dx Test)

Beyond the preview

Go deeper on Provista Life Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Provista Life Sciences.

Explore the full profile